Published December 2021 | Version v1
Journal article

Extraction, purification and radioiodination of Khellin as cancer theranostic agent

  • 1. Radioisotopes Production Facility, Second Egyptian Research Reactor Complex, Egyptian Atomic Energy Authority (EAEA), Cairo, 13759 (Egypt)
  • 2. Labeled Compounds Department, Hot Laboratories Centre, Egyptian Atomic Energy Authority (EAEA), Cairo, 13759 (Egypt)
  • 3. Radioactive Isotopes and Generator Department, Hot Laboratories Centre, Egyptian Atomic Energy Authority (EAEA), Cairo, 13759 (Egypt)
  • 4. Nuclear Chemistry Department, Hot Laboratories Centre, Egyptian Atomic Energy Authority (EAEA), Cairo, 13759 (Egypt)
  • 5. Analytical Chemistry Department, Benha University, Benha, 13511 (Egypt)

Description

Highlights: • Khellin was extracted from the fresh fruits of Ammivisnaga and full characterized. • Radiolabeling of Khellin with 131I was successfully achieved with a high radiochemical yield. • In-vivo study of [131I]iodo-khellin in tumour bearing mice revealed its preferential localization at tumour tissue. • The docking study confirmed good affinity of iodo-khellin to the predicted targets. Khellin was successfully extracted from Ammi visnaga fruits with a recovery percent of 96.15%. Next radio-iodination of Khellin was successfully achieved with a high yield. The biodistribution study of [131I]iodo-khellin in tumour bearing mice revealed that khellin preferentially localization at tumour tissue. Target prediction study for [131I]iodo-khellin revealed that PI3K and VEGFR are potential targets for iodo-khellin with good affinity. The results of this study potentiate [131I]iodo-khellin as a good theranostic agent for tumour imaging and therapy.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.apradiso.2021.109970

Additional details

Identifiers

DOI
10.1016/j.apradiso.2021.109970;
PII
S0969804321003663;

Publishing Information

Journal Title
Applied Radiation and Isotopes
Journal Volume
178
Journal Page Range
vp.
ISSN
0969-8043
CODEN
ARISEF

Optional Information

Copyright
Copyright (c) 2021 Elsevier Ltd. All rights reserved.